JONBUR Research · Update note
You're reading an earlier report from Oct 14, 2026. See the latest report
Alteogen · 196170 · Biotech & Pharma
Alteogen Files Merger Securities Registration Statement for 600,477 New Shares Worth ₩156.9B
Alteogen filed a securities registration statement on 2026-10-14 for its merger, covering 600,477 new common shares with a total offering value of ₩156.9B. This gives the first concrete size for the merger announced on October 6, but the excerpt does not show the merger partner, ratio or purpose.
Written Oct 14, 2026 · Data as of Oct 13, 2026 · 0 views
This is not financial advice. The report does not recommend buying or selling anything.
What happened
On 2026-10-14 Alteogen filed a securities registration statement (merger) with the Financial Services Commission. The securities are 600,477 registered common shares, with a total offering amount of ₩156,931,661,565 (about ₩156.9B).
Against 42,264,250 listed shares, the new shares equal about 1.4% of the current share count. The ₩156.9B amount equals about 1.7% of the market capitalization of ₩9.49T on 2026-10-13, and about 61.8% of trailing revenue of ₩254.0B. These are our own comparisons using the filed figures.
The excerpt covers the cover page and the start of the risk summary. The risks cited include global economic conditions, US tariff policy on patented drugs (a 15% rate applies to Korea) and interest rates. The excerpt does not name the merger counterparty, the merger ratio, the effective date or the effect on earnings. The cover page lists a second location, Alteogen Biologics, in Seoul, but the excerpt does not explain its role in the merger.
Every earlier JONBUR Research report and update note on Alteogen, with Pro.
Unlock with ProModel estimate of fair value
The valuation model has no estimate for this company yet (not enough data, or no positive value with the base case).
Filings and data used
- Securities registration statementOct 14, 2026
- Investor relations (IR) eventOct 8, 2026
- Determination of Shareholder Register Closure Period or Record DateOct 6, 2026
- Merger decisionOct 6, 2026
- Added attachment: Merger decisionOct 6, 2026
- Rights offering (paid-in capital increase) decisionOct 6, 2026
- Rights offering (paid-in capital increase) decisionOct 6, 2026
- Rights offering (paid-in capital increase) decisionOct 6, 2026
- Rights offering (paid-in capital increase) decisionOct 6, 2026
- Investor relations (IR) eventSep 21, 2026
- Major management matter relevant to investorsSep 2, 2026
- Major management matter relevant to investorsAug 31, 2026
- Daily prices up to 2026-10-13
- Financial statements, trailing 12 months as of H1 2026
Report history
- Oct 28, 2026Update noteM&A / restructuringAlteogen Receives Request to Amend Merger Securities Registration Statement
- Oct 14, 2026Update noteM&A / restructuringAlteogen Files Merger Securities Registration Statement for 600,477 New Shares Worth ₩156.9B
- Oct 13, 2026InitiationAlteogen: Sharp Profit Growth Meets a 49.8% One-Year Share Price Decline and New Merger and Rights Offering Filings
Source: KRX statistical information